Susquehanna International Group’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,000
| Closed | -$170K | – | 11933 |
|
|
2024
Q1 | $170K | Buy |
12,000
+6,530
| +119% | +$99.3K | ﹤0.01% | 10780 |
|
|
2023
Q4 | $41K | Hold |
5,470
| – | – | ﹤0.01% | 11788 |
|
|
2023
Q3 | $82K | Sell |
5,470
-160
| -3% | -$2.87K | ﹤0.01% | 11059 |
|
|
2023
Q2 | $89.5K | Buy |
5,630
+90
| +2% | +$946 | ﹤0.01% | 11030 |
|
|
2023
Q1 | $39.9K | Sell |
5,540
-27,130
| -83% | -$192K | ﹤0.01% | 11794 |
|
|
2022
Q4 | $189K | Buy |
32,670
+2,710
| +9% | +$20.5K | ﹤0.01% | 10214 |
|
|
2022
Q3 | $285K | Sell |
29,960
-1,810
| -6% | -$23.8K | ﹤0.01% | 9921 |
|
|
2022
Q2 | $381K | Sell |
31,770
-12,800
| -29% | -$134K | ﹤0.01% | 8918 |
|
|
2022
Q1 | $584K | Sell |
44,570
-40,750
| -48% | -$596K | ﹤0.01% | 8575 |
|
|
2021
Q4 | $1.5M | Buy |
85,320
+10,170
| +14% | +$204K | ﹤0.01% | 6205 |
|
|
2021
Q3 | $1.63M | Buy |
75,150
+52,610
| +233% | +$1.34M | ﹤0.01% | 6279 |
|
|
2021
Q2 | $789K | Buy |
22,540
+13,580
| +152% | +$731K | ﹤0.01% | 8415 |
|
|
2021
Q1 | $883K | Sell |
8,960
-14,570
| -62% | -$1.75M | ﹤0.01% | 8054 |
|
|
2020
Q4 | $2.55M | Buy |
23,530
+8,940
| +61% | +$1.11M | ﹤0.01% | 4591 |
|
|
2020
Q3 | $1.5M | Sell |
14,590
-800
| -5% | -$120K | ﹤0.01% | 5177 |
|
|
2020
Q2 | $3.21M | Buy |
15,390
+11,480
| +294% | +$2.03M | ﹤0.01% | 3686 |
|
|
2020
Q1 | $382K | Sell |
3,910
-36,160
| -90% | -$4.22M | ﹤0.01% | 7498 |
|
|
2019
Q4 | $4.62M | Sell |
40,070
-20,130
| -33% | -$1.77M | ﹤0.01% | 3076 |
|
|
2019
Q3 | $3.28M | Buy |
60,200
+51,130
| +564% | +$5.76M | ﹤0.01% | 3349 |
|
|
2019
Q2 | $1.08M | Buy |
+9,070
| New | +$750K | ﹤0.01% | 5476 |
|
|
2019
Q1 | – | Sell |
-1,720
| Closed | -$54K | – | 8718 |
|
|
2018
Q4 | $54K | Sell |
1,720
-3,080
| -64% | -$125K | ﹤0.01% | 8453 |
|
|
2018
Q3 | $290K | Sell |
4,800
-1,260
| -21% | -$70.8K | ﹤0.01% | 7550 |
|
|
2018
Q2 | $321K | Buy |
6,060
+2,550
| +73% | +$153K | ﹤0.01% | 7695 |
|
|
2018
Q1 | $204K | Buy |
3,510
+1,300
| +59% | +$80.9K | ﹤0.01% | 8289 |
|
|
2017
Q4 | $77K | Buy |
+2,210
| New | +$72.7K | ﹤0.01% | 8784 |
|
|
2016
Q2 | – | Sell |
-3,060
| Closed | -$158K | – | 8465 |
|
|
2016
Q1 | $158K | Buy |
3,060
+640
| +26% | +$35.7K | ﹤0.01% | 8170 |
|
|
2015
Q4 | $230K | Sell |
2,420
-7,640
| -76% | -$671K | ﹤0.01% | 8188 |
|
|
2015
Q3 | $829K | Sell |
10,060
-3,160
| -24% | -$404K | ﹤0.01% | 6131 |
|
|
2015
Q2 | $2.15M | Buy |
13,220
+10,050
| +317% | +$3.39M | ﹤0.01% | 4568 |
|
|
2015
Q1 | $1.28M | Buy |
+3,170
| New | +$1.34M | ﹤0.01% | 5251 |
|
Susquehanna International Group's ADVM Position: Q4 2025 in Review
Susquehanna International Group sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 26,255 shares — an estimated $119K sold.
Susquehanna International Group first reported a position in ADVM in Q1 2015 and held it in 30 quarters. The position peaked at $6.02M in Q1 2015. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.
- Susquehanna International Group reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
- Susquehanna International Group sold 26,255 Adverum Biotechnologies shares in Q4 2025, an estimated $119K.
- Susquehanna International Group first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 30 quarters.
- Susquehanna International Group's Adverum Biotechnologies position peaked at $6.02M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.